FKB - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Serial Number
79141948
Registration Number
4779408
Word Mark
FKB
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2022-02-11
Filing Date
2013-11-15
Registration Number
4779408
Registration Date
2015-07-28
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2015-05-12
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
CRAWFORD, MARY E
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases; Pharmaceutical preparations for use in connection with humans for the treatment of parasitic diseases; Pharmaceutical preparations for use in connection with humans for the prevention of parasitic diseases; Pharmaceutical preparations for use in connection with humans for the treatment of neoplasms; Pharmaceutical preparations for use in connection with humans for the prevention of neoplasms; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the blood; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the blood; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of blood-forming organs; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of blood-forming organs; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of certain disorders involving the immune mechanism; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of certain disorders involving the immune mechanism; Pharmaceutical preparations for use in connection with humans for the treatment of endocrine diseases; Pharmaceutical preparations for use in connection with humans for the prevention of endocrine diseases; Pharmaceutical preparations for use in connection with humans for the treatment of nutritional diseases; Pharmaceutical preparations for use in connection with humans for the prevention of nutritional diseases; Pharmaceutical preparations for use in connection with humans for the treatment of metabolic diseases; Pharmaceutical preparations for use in connection with humans for the prevention of metabolic diseases; Pharmaceutical preparations for use in connection with humans for the treatment of mental disorders; Pharmaceutical preparations for use in connection with humans for the prevention of mental disorders ; Pharmaceutical preparations for use in connection with humans for the treatment of behavioural disorders; Pharmaceutical preparations for use in connection with humans for the prevention of behavioural disorders; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the nervous system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the nervous system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the eye; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the eye; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of eye adnexa; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of eye adnexa; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the ear; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the ear; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the mastoid process; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the mastoid process; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the circulatory system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the circulatory system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the respiratory system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the respiratory system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the digestive system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the digestive system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the skin; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the skin; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of subcutaneous tissue; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of subcutaneous tissue; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the musculoskeletal system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the musculoskeletal system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the connective tissue; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the connective tissue; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the genitourinary system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases and diabetes occurred in pregnancy; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases and diabetes occurred in pregnancy; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in childbirth; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in childbirth; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in the puerperium; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in the puerperium; Pharmaceutical preparations for use in connection with humans for the treatment of nutritional deficiency conditions originating in the perinatal period; Pharmaceutical preparations for use in connection with humans for the prevention of nutritional deficiency conditions originating in the perinatal period; Pharmaceutical preparations for use in connection with humans for the treatment of congenital malformations; Pharmaceutical preparations for use in connection with humans for the prevention of congenital malformations; Pharmaceutical preparations for use in connection with humans for the treatment of deformations; Pharmaceutical preparations for use in connection with humans for the prevention of deformations; Pharmaceutical preparations for use in connection with humans for the treatment of chromosomal abnormalities; Pharmaceutical preparations for use in connection with humans for the prevention of chromosomal abnormalities; Prescribed pharmaceutical preparations for the treatment of infectious diseases; Prescribed pharmaceutical preparations for the prevention of infectious diseases; Prescribed pharmaceutical preparations for the treatment of parasitic diseases; Prescribed pharmaceutical preparations for the prevention of parasitic diseases; Prescribed pharmaceutical preparations for the treatment of neoplasms; Prescribed pharmaceutical preparations for the prevention of neoplasms; Prescribed pharmaceutical preparations for the treatment of diseases of the blood; Prescribed pharmaceutical preparations for the prevention of diseases of the blood Prescribed pharmaceutical preparations for the treatment of diseases of blood-forming organs; Prescribed pharmaceutical preparations for the prevention of diseases of blood-forming organs; Prescribed pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; Prescribed pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; Prescribed pharmaceutical preparations for the treatment of endocrine diseases; Prescribed pharmaceutical preparations for the prevention of endocrine diseases; Prescribed pharmaceutical preparations for the treatment of nutritional diseases; Prescribed pharmaceutical preparations for the prevention of nutritional diseases; Prescribed pharmaceutical preparations for the treatment of metabolic diseases; Prescribed pharmaceutical preparations for the prevention of metabolic diseases; Prescribed pharmaceutical preparations for the treatment of mental disorders; Prescribed pharmaceutical preparations for the prevention of mental disorders; Prescribed pharmaceutical preparations for the treatment of behavioural disorders; Prescribed pharmaceutical preparations for the prevention of behavioural disorders; Prescribed pharmaceutical preparations for the treatment of diseases of the nervous system; Prescribed pharmaceutical preparations for the prevention of diseases of the nervous system; Prescribed pharmaceutical preparations for the treatment of diseases of the eye; Prescribed pharmaceutical preparations for the prevention of diseases of the eye; Prescribed pharmaceutical preparations for the treatment of diseases of eye adnexa; Prescribed pharmaceutical preparations for the prevention of diseases of eye adnexa; Prescribed pharmaceutical preparations for the treatment of diseases of the ear; Prescribed pharmaceutical preparations for the prevention of diseases of the ear; Prescribed pharmaceutical preparations for the treatment of diseases of the mastoid process; Prescribed pharmaceutical preparations for the prevention of diseases of the mastoid process; Prescribed pharmaceutical preparations for the treatment of diseases of the circulatory system; Prescribed pharmaceutical preparations for the prevention of diseases of the circulatory system; Prescribed pharmaceutical preparations for the treatment of diseases of the respiratory system; Prescribed pharmaceutical preparations for the prevention of diseases of the respiratory system; Prescribed pharmaceutical preparations for the treatment of diseases of the digestive system; Prescribed pharmaceutical preparations for the prevention of diseases of the digestive system; Prescribed pharmaceutical preparations for the treatment of diseases of the skin; Prescribed pharmaceutical preparations for the prevention of diseases of the skin; Prescribed pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; Prescribed pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; Prescribed pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; Prescribed pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; Prescribed pharmaceutical preparations for the treatment of diseases of the connective tissue; Prescribed pharmaceutical preparations for the prevention of diseases of the connective tissue; Prescribed pharmaceutical preparations for the treatment of diseases of the genitourinary system; Prescribed pharmaceutical preparations for the prevention of diseases of the genitourinary system; Prescribed pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; Prescribed pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; Prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; Prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; Prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; Prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; Prescribed pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; Prescribed pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; Prescribed pharmaceutical preparations for the treatment of congenital malformations; Prescribed pharmaceutical preparations for the prevention of congenital malformations; Prescribed pharmaceutical preparations for the treatment of deformations; Prescribed pharmaceutical preparations for the prevention of deformations; Prescribed pharmaceutical preparations for the treatment of chromosomal abnormalities; Prescribed pharmaceutical preparations for the prevention of chromosomal abnormalities; Biological pharmaceutical preparations for the treatment of infectious diseases; Biological pharmaceutical preparations for the prevention of infectious diseases; Biological pharmaceutical preparations for the treatment of parasitic diseases; Biological pharmaceutical preparations for the prevention of parasitic diseases; Biological pharmaceutical preparations for the treatment of neoplasms; Biological pharmaceutical preparations for the prevention of neoplasms; Biological pharmaceutical preparations for the treatment of diseases of the blood; Biological pharmaceutical preparations for the prevention of diseases of the blood; Biological pharmaceutical preparations for the treatment of diseases of blood-forming organs; Biological pharmaceutical preparations for the prevention of diseases of blood-forming organs; Biological pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; Biological pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; Biological pharmaceutical preparations for the treatment of endocrine diseases; Biological pharmaceutical preparations for the prevention of endocrine diseases; Biological pharmaceutical preparations for the treatment of nutritional diseases; Biological pharmaceutical preparations for the prevention of nutritional diseases; Biological pharmaceutical preparations for the treatment of metabolic diseases; Biological pharmaceutical preparations for the prevention of metabolic diseases; Biological pharmaceutical preparations for the treatment of mental disorders; Biological pharmaceutical preparations for the prevention of mental disorders; Biological pharmaceutical preparations for the treatment of behavioural disorders; Biological pharmaceutical preparations for the prevention of behavioural disorders; Biological pharmaceutical preparations for the treatment of diseases of the nervous system; Biological pharmaceutical preparations for the prevention of diseases of the nervous system; Biological pharmaceutical preparations for the treatment of diseases of the eye; Biological pharmaceutical preparations for the prevention of diseases of the eye; Biological pharmaceutical preparations for the treatment of diseases of eye adnexa; Biological pharmaceutical preparations for the prevention of diseases of eye adnexa; Biological pharmaceutical preparations for the treatment of diseases of the ear; Biological pharmaceutical preparations for the prevention of diseases of the ear; Biological pharmaceutical preparations for the treatment of diseases of the mastoid process; Biological pharmaceutical preparations for the prevention of diseases of the mastoid process; Biological pharmaceutical preparations for the treatment of diseases of the circulatory system; Biological pharmaceutical preparations for the prevention of diseases of the circulatory system; Biological pharmaceutical preparations for the treatment of diseases of the respiratory system; Biological pharmaceutical preparations for the prevention of diseases of the respiratory system; Biological pharmaceutical preparations for the treatment of diseases of the digestive system; Biological pharmaceutical preparations for the prevention of diseases of the digestive system; Biological pharmaceutical preparations for the treatment of diseases of the skin; Biological pharmaceutical preparations for the prevention of diseases of the skin; Biological pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; Biological pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; Biological pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; Biological pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; Biological pharmaceutical preparations for the treatment of diseases of the connective tissue; Biological pharmaceutical preparations for the prevention of diseases of the connective tissue; Biological pharmaceutical preparations for the treatment of diseases of the genitourinary system; Biological pharmaceutical preparations for the prevention of diseases of the genitourinary system; Biological pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; Biological pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; Biological pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; Biological pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; Biological pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; Biological pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; Biological pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; Biological pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; Biological pharmaceutical preparations for the treatment of congenital malformations; Biological pharmaceutical preparations for the prevention of congenital malformations; Biological pharmaceutical preparations for the treatment of deformations; Biological pharmaceutical preparations for the prevention of deformations; Biological pharmaceutical preparations for the treatment of chromosomal abnormalities; Biological pharmaceutical preparations for the prevention of chromosomal abnormalities;bandages for dressings
Goods and Services
Apparatus for drug administration, namely, drug delivery systems, injector, autoinjector; Therapeutic inhalers, sold empty; High frequency electromagnetic therapy apparatus; Oxygen inhalaters for therapeutic purposes; Ultraviolet radiator units for therapeutic purposes; Defibrillators; Pneumothorax apparatus, namely, medical apparatus for diagnosing or treating respiratory conditions; Heart pacemakers; Mercury arc lamp units for therapeutic purposes; Infrared radiator units for therapeutic purposes; Puncture apparatus for therapeutic purposes, namely, medical devices for closing wounds; Lavage apparatus for therapeutic purposes, namely, apparatus for washing out body cavities; Carbon arc lamp units for therapeutic purposes; Injection syringes, syringe barrels; Injection needles; Infusion apparatus for therapeutic purposes, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; Ultrasonic therapy machines and apparatus; Short wave therapy machines and apparatus; Therapeutic bath apparatus and instruments, namely, appliances for washing body cavities; Massage apparatus for medical purposes; Low frequency electric therapy apparatus; Static electric therapy apparatus; Dialyzers, namely, blood component separation apparatus for medical purposes; Acupuncture needles; Sprayers for medical purposes, namely, drug delivery sprayers sold empty; Suture apparatus for medical purposes, namely, suture needles and suture materials; Radioisotope therapy apparatus and instruments; Incubators for babies; Blood transfusion apparatus; Containers and trays specially designed for transporting and holding pharmaceuticals; Injection device for pharmaceuticals; Injection instruments without needles; Injection instruments with needles
Goods and Services
Providing information concerning commercial sales in the field of pharmaceuticals
Goods and Services
Custom manufacture of pharmaceuticals
Goods and Services
Pharmaceutical research; pharmaceutical development
Goods and Services
Pharmaceutical information services provided via the Internet, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services provided via the Internet; providing medical information
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2022-02-11
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2022-02-11
Primary Code
010
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2022-02-11
Primary Code
035
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2022-02-11
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2022-02-11
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2022-02-11
Primary Code
044
Correspondences
Name
Kaushal Odedra
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1190741
International Registration Date
2013-11-15
International Publication Date
2014-01-30
International Renewal Date
2023-12-15
Auto Protection Date
2017-04-08
International Status
001 - Request for extension of protection established
International Status Date
2014-01-30
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2014-01-30 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2014-01-31 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2014-02-04 | APPLICATION FILING RECEIPT MAILED |
2014-03-24 | ASSIGNED TO EXAMINER |
2014-03-24 | NON-FINAL ACTION WRITTEN |
2014-03-25 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2014-03-25 | REFUSAL PROCESSED BY MPU |
2014-03-25 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2014-04-25 | REFUSAL PROCESSED BY IB |
2014-06-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2014-06-19 | ASSIGNED TO LIE |
2014-06-30 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-06-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-07-21 | NON-FINAL ACTION WRITTEN |
2014-07-22 | NON-FINAL ACTION MAILED |
2015-01-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2015-01-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2015-01-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2015-02-05 | FINAL REFUSAL WRITTEN |
2015-02-06 | FINAL REFUSAL MAILED |
2015-03-19 | EXAMINERS AMENDMENT -WRITTEN |
2015-03-19 | EXAMINER'S AMENDMENT ENTERED |
2015-03-19 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2015-03-20 | EXAMINERS AMENDMENT MAILED |
2015-04-07 | ASSIGNED TO LIE |
2015-04-07 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2015-04-22 | NOTICE OF PUBLICATION |
2015-04-22 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2015-04-22 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2015-05-08 | NOTIFICATION PROCESSED BY IB |
2015-05-12 | PUBLISHED FOR OPPOSITION |
2015-07-01 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
2015-07-01 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2015-07-17 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2015-07-28 | REGISTERED-PRINCIPAL REGISTER |
2015-10-09 | CORRECTION TRANSACTION RECEIVED FROM IB |
2015-10-20 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
2015-10-28 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2015-12-15 | GENERIC MADRID TRANSACTION CREATED |
2015-12-15 | GENERIC MADRID TRANSACTION SENT TO IB |
2016-01-31 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2022-02-11 | CANCELLED SECTION 71 |